About this item:

188 Views | 223 Downloads

Author Notes:

Karla I. Galaviz, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, CNR Building Room 6011, Atlanta, GA, USA. Email: kgalavi@emory.edu

Jonathan Colasanti, MD, MSPH https://orcid.org/0000-0002-5491-3388

K.I.G and J.C. designed the study, provided guidance for statistical analyses, provided interpretation of study findings, and drafted the manuscript.

R.V. conducted the statistical analyses, contributed to interpretation of findings, critically revised the manuscript, and approved submission.

X.C. and S.H.W provided guidance for statistical analyses, contributed to interpretation of findings, critically revised the manuscript, and approved submission.

A.G. contributed to interpretation of findings, provided guidance for study conduction, critically revised the manuscript, and approved submission.

B.K.A., VCM, and M.K.A. contributed to study design, interpretation of findings, critically revised the manuscript, and approved submission.

The views expressed are those of the authors and do not reflect the official views of the Uniformed Services University of the Health Sciences, the National Institutes of Health or the Department of Health and Human Services, the Department of Defense, or the Departments of the Army, Navy or Air Force, or the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Subjects:

Research Funding:

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The National Institute of Diabetes and Digestive and Kidney Diseases [P30DK111024]; the National Heart, Lung, and Blood Institute [1K01HL149479-01]; the Infectious Disease Clinical Research Program, a Department of Defense program executed through the Uniformed Services University of the Health Sciences; the National Institute of Allergy and Infectious Diseases [Y1-AI-5072]; the Emory University Center for AIDS Research [P30AI050409]; and the Veterans Aging Cohort Study [U01AA020790].

Keywords:

  • care continuum
  • equity
  • patient care
  • race

The Intersection of HIV, Diabetes, and Race: Exploring Disparities in Diabetes Care among People Living with HIV

Tools:

Journal Title:

Journal of the International Association of Providers of AIDS Care

Volume:

Volume 19

Publisher:

, Pages 2325958220904241-2325958220904241

Type of Work:

Article | Final Publisher PDF

Abstract:

In a setting of universal health care access, we compared diabetes control between Caucasians and African Americans (AA) living with HIV. This was a cross-sectional analysis of data from a cohort study among military members living with HIV and diabetes. Using adjusted logistic regression models, we compared proportions of Caucasians and AA meeting the following diabetes treatment goals: hemoglobin A1c <7.0%, blood pressure (BP) <140/90 mm Hg, low density lipoprotein cholesterol <100 mg/dL, and not smoking. We included 107 Caucasian (mean age 37 years) and 126 AA (mean age 33 years) participants. A similar proportion of Caucasians and AA were prescribed diabetes (∼60%) and BP (∼80%) medications. Yet, more Caucasians met the BP treatment goal (77% [54%, 90%]) than AA (61% [36%, 82%]). Thus, more Caucasians met the combined A1c, BP, and cholesterol goals for diabetes control (25% [10%, 49%]) than AA (13% [5%, 31%]). Despite having equal access to health care, AA in this study have poorer diabetes control than Caucasians.

Copyright information:

© The Author(s) 2020.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/).
Export to EndNote